Understanding EUCAST recommendations for Antimicrobial Susceptibility Testing (AST)

If you missed the live event, you can view the recorded content below.

A live event held on Thursday 7 October 2021
Chair: Dr Robin Howe, National Clinical Lead for Public Health Wales Microbiology

This webinar is an RCPath accredited online learning event. 

Programme and registration details below.

 

Programme

Welcome & introduction
Dr Robin Howe, National Clinical Lead for Public Health Wales MicrobiologView bio

The redefinition of the “I” category and ATU
Dr Mandy Wootton, Consultant Scientist / Operational Manager, Specialist Antimicrobial Chemotherapy Unit, Public Health Wales, University Hospital of Wales –  View bio

Implementing the changes – Scotland
Dr Mairi MacLeod, Consultant Microbiologist, Glasgow Royal Infirmary & Chair of Scottish Microbiology and Virology Network (SMVN)  AMR Diagnostics subgroup

Implementing the changes – Wales
Dr Lim Jones, Consultant Microbiologist, Public Health Wales, Cardiff

Differences between UK and EUCAST use aminoglycosides
Professor Alasdair MacGowan, Consultant in Infection at North Bristol NHS Trust and Professor of Antimicrobial Therapeutics at the University of Bristol – View bio

Panel discussion and Q&A
Chaired by Dr Robin Howe, National Clinical Lead for Public Health Wales Microbiology – View bio

For any queries regarding this event, please contact Esme Carruthers.

GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member
I have read and agree to the Privacy Policy

Having trouble finding what you're after?

Top